Standards; Pharmaceutical/API Drug Impurities/Metabolites;
應(yīng)用:
XL184 can be used in biological study. Computational network biological approach based on pathway cross-talk inhibition identified new synergistic drug combinations using raloxifene and cabozantinib for treatment of human breast cancer in xenograft mouse model. Potent c-MET inhibitor.
?您的位置：
